Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program eases diabetes stress and boosts blood sugar control in young people

NCT ID NCT05413239

Symptom relief Sponsor: Joslin Diabetes Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested a behavioral program for 217 teens and young adults (ages 14-25) with type 1 diabetes. The program included 12 one-on-one sessions focused on improving blood sugar levels and reducing diabetes-related distress. Researchers measured changes in time in range (blood sugar 70-180 mg/dL) and A1c over 12 months. The goal was to see if this support program could help young people better manage their diabetes and feel less stressed about it.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
psychoeducation program (behavioral intervention)
What this could lead to
If successful, this program could offer a practical way to help young people with type 1 diabetes improve blood sugar control and feel less overwhelmed by their condition.
What could go wrong
This is a completed behavioral study, not a drug trial. Results may not apply to everyone, and benefits depend on individual engagement. No major physical risks, but the program may not work for all participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

217 people

The number who actually took part.

Started

Jul 2022

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

14 to 25 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 14-25 years * Diagnosis of type 1 diabetes (according to ADA criteria) * Type 1 diabetes duration ≥12 months * A1c 7-13% * Smartphone or regular access to wifi via computer * Fluency in English at a 5th grade level or higher (based on investigator assessment of grade level in school or highest grade level achieved and presence in mainstream academic classes) Exclusion Criteria: * Physical or mental health condition that in the determination of the investigators may limit the ability to fully participate in the study (e.g., autism) * Participation in another intervention study within the last 3 months * Currently pregnant or intending to become pregnant during the study (assessed by self-report)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 1 diabetes are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 1 diabetes

Contacts and locations

Locations

  • Joslin Diabetes Center

    Boston, Massachusetts, 02215, United States

  • Stanford University

    Palo Alto, California, 94305, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.